Pregnane X receptor as a target for treatment of inflammatory bowel disorders
- 30 June 2012
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 33 (6), 323-330
- https://doi.org/10.1016/j.tips.2012.03.003
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- MR Enterography Findings of Inflammatory Bowel Disease in Pediatric PatientsAmerican Journal of Roentgenology, 2011
- IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivoInflammatory Bowel Diseases, 2011
- Pregnane X receptor‐ and CYP3A4‐humanized mouse models and their applicationsBritish Journal of Pharmacology, 2011
- Probable Interaction Between Warfarin and Rifaximin in a Patient Treated for Small Intestine Bacterial OvergrowthAnnals of Pharmacotherapy, 2011
- Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-AnalysisThe American Journal of Gastroenterology, 2011
- Estrogen receptor-β signaling modulates epithelial barrier functionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Acetylation of pregnane X receptor protein determines selective function independent of ligand activationBiochemical and Biophysical Research Communications, 2011
- Differential Role of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein in Toll-Like Receptor 2-Mediated Regulation of Gene Expression of Hepatic Cytokines and Drug-Metabolizing EnzymesDrug Metabolism and Disposition, 2011
- PGE2promotes Ca2+-mediated epithelial barrier disruption through EP1and EP4receptors in Caco-2 cell monolayersAmerican Journal of Physiology-Cell Physiology, 2010
- Pregnane X receptor suppresses proliferation and tumourigenicity of colon cancer cellsBritish Journal of Cancer, 2010